Fiber Choice Weight Management Drug Interactions
Currently displaying a list of 82 drugs known to interact with Fiber Choice Weight Management (chromium picolinate / inulin).
- 1 major drug interaction
- 80 moderate drug interactions
- 1 minor drug interaction
Medications known to interact with Fiber Choice Weight Management
Note: Showing generic names only.
A
B
C
D
E
G
I
- ibandronate
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
L
- lactulose
- levofloxacin
- levothyroxine
- levothyroxine / liothyronine
- linaclotide
- linagliptin
- liothyronine
- liotrix
- liraglutide
- lixisenatide
- lomefloxacin
M
N
O
P
R
S
T
- thyroid desiccated
- thyrotropin alpha
- tiludronate
- tirzepatide
- tolazamide
- tolbutamide
- troglitazone
- trovafloxacin
V
Fiber Choice Weight Management disease interactions
There are 4 disease interactions with Fiber Choice Weight Management (chromium picolinate / inulin) which include:
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
- malabsorption syndromes
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.